Prosecution Insights
Last updated: October 25, 2026

Riken

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems

33 pending office actions • 27 art units • 32 examiners • 0 of 33 (0%) have an AI response strategy ready • 37 patents granted in the last 365 days

Analysis

Riken has 33 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a distinct examiner, while the portfolio spans 28 distinct art units, indicating broad technical and examiner distribution.

KIM, ANDREW SANG is the busiest identified examiner, with 1 pending matter. The absence of repeated examiner assignments supports individualized prosecution planning, with centralized coordination focused on consistent treatment of portfolio-wide technical themes.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

33
Total Pending OAs
16
Non-Final OAs
16
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
5
Due this month
2
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (5)Due ≤ 60 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

20
Hard (61%)
13
Medium (39%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only3 (9%)
§101 + other6 (18%)
§103 only11 (33%)
§102 only2 (6%)
Multi-statute (no §101)11 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
48% of docket
1
Information Tech
3% of docket
0
Communications
0% of docket
3
Semiconductors
9% of docket
12
Mechanical / Eng
36% of docket
1
Business / Other
3% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

330 h
Manual time on pending OAs
66 h
Time saved (low, 20%)
115 h
Time saved (mid, 35%)
2.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BARR, MARY EVANGELINE 2 36.1% +32.5%
KIM, ANDREW SANG 1 84.0% +5.0%
GO, JOHN PHILIP 1 33.9% +43.3%
DOUMBIA, MOHAMED 1 73.6% +28.6%
HIGGS, STELLA EUN 1 39.1% +34.4%
SALAZAR JR, JORGE L 1 95.1% +6.1%
ARIANI, KADE 1 75.0% +32.0%
RAGHU, GANAPATHIRAM 1 73.7% +26.5%
ABEYRATNE-PERERA, HASHANTHI KOMITIGE 1 0.0% +0.0%
DAVIS, SHARON M 1 68.1% +26.6%

Hard Cases (20)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18034621 CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL EXPRESSING CXCL12 RECEPTOR DUNN, LINDSAY MICHELLE 13d
19111824 METHOD AND APPARATUS FOR DETERMINING RISKS OF NEURODEGENERATIVE DISEASES HIGGS, STELLA EUN 14d
18591144 RECORDING MEDIUM, INFORMATION PROCESSING SYSTEM, AND DATA PROCESSING SYSTEM WONG, ERIC TAK WAI 14d
17928184 METHOD FOR TREATING CELL POPULATION AND METHOD FOR ANALYZING GENES INCLUDED IN CELL POPULATION CHUNDURU, SURYAPRABHA 20d
19483072 SYSTEM KIM, ANDREW SANG —
19125969 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND COMPUTER PROGRAM GO, JOHN PHILIP —
19114638 SUGGESTION DEVICE, SUGGESTION METHOD, SUGGESTION SYSTEM, PROGRAM, AND INFORMATION RECORDING MEDIUM FOR SUGGESTING FACTOR PARAMETERS FOR ESTIMATING TARGET LABEL BARR, MARY EVANGELINE —
19104128 SUPERCONDUCTIVE PASSIVE ELEMENT, MANUFACTURING METHOD FOR SUPERCONDUCTIVE PASSIVE ELEMENT, AND DEVICE INCLUDING SAID PASSIVE ELEMENT SALAZAR JR, JORGE L —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19111824 METHOD AND APPARATUS FOR DETERMINING RISKS OF NEURODEGENERATIVE DISEASES HIGGS, STELLA EUN 14d
19125969 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND COMPUTER PROGRAM GO, JOHN PHILIP —
19096998 FLUORESCENCE DETECTION DEVICE DOUMBIA, MOHAMED —
19114638 SUGGESTION DEVICE, SUGGESTION METHOD, SUGGESTION SYSTEM, PROGRAM, AND INFORMATION RECORDING MEDIUM FOR SUGGESTING FACTOR PARAMETERS FOR ESTIMATING TARGET LABEL BARR, MARY EVANGELINE —
18849210 COMBINATION DRUG FOR TREATING MALIGNANT TUMOR ARIANI, KADE —
18851231 METHOD FOR PRODUCING METHACRYLIC ACID RAGHU, GANAPATHIRAM —
18833375 SYSTEM, METHOD, AND PROGRAM FOR QUANTIFYING EFFECTS OF CONDITION CHANGE PERTAINING TO SUBJECT BARR, MARY EVANGELINE —
18713123 RADIONUCLIDE PRODUCTION METHOD, TARGET HOLDING DEVICE FOR QUANTUM BEAM IRRADIATION, SYSTEM, AND TARGET DAVIS, SHARON M —

Top Art Units

Art UnitApps
3681 2
3682 2
1652 2
1632 2
3675 2
3668 1
2877 1
2843 1
1651 1
3646 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19483072 SYSTEM KIM, ANDREW SANG 3668 §102§103§112 Non-Final OA — Pending Nov 10, 2025
19125969 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND COMPUTER PROGRAM GO, JOHN PHILIP 3681 §101§103 Final Rejection — Pending Apr 30, 2025
19096998 FLUORESCENCE DETECTION DEVICE DOUMBIA, MOHAMED 2877 §103Other Non-Final OA — Pending Apr 01, 2025
19114638 SUGGESTION DEVICE, SUGGESTION METHOD, SUGGESTION SYSTEM, PROGRAM, AND INFORMATION RECORDING MEDIUM FOR SUGGESTING FACTOR PARAMETERS FOR ESTIMATING TARGET LABEL BARR, MARY EVANGELINE 3682 §102§112 Final Rejection — Pending Mar 24, 2025
19111824 METHOD AND APPARATUS FOR DETERMINING RISKS OF NEURODEGENERATIVE DISEASES HIGGS, STELLA EUN 3681 §101 Final Rejection 14d Pending Mar 14, 2025
19104128 SUPERCONDUCTIVE PASSIVE ELEMENT, MANUFACTURING METHOD FOR SUPERCONDUCTIVE PASSIVE ELEMENT, AND DEVICE INCLUDING SAID PASSIVE ELEMENT SALAZAR JR, JORGE L 2843 §102§103§112 Non-Final OA — Pending Feb 14, 2025
18849210 COMBINATION DRUG FOR TREATING MALIGNANT TUMOR ARIANI, KADE 1651 §102§103 Non-Final OA — Pending Nov 20, 2024
18851231 METHOD FOR PRODUCING METHACRYLIC ACID RAGHU, GANAPATHIRAM 1652 §101§102§103§112 Non-Final OA — Pending Sep 26, 2024
18833375 SYSTEM, METHOD, AND PROGRAM FOR QUANTIFYING EFFECTS OF CONDITION CHANGE PERTAINING TO SUBJECT BARR, MARY EVANGELINE 3682 §102§103 Final Rejection — Pending Jul 25, 2024
18688649 KIDNEY ORGANOID AND METHOD FOR PRODUCING SAME ABEYRATNE-PERERA, HASHANTHI KOMITIGE 1632 §101§112 Non-Final OA — Pending May 23, 2024
18713123 RADIONUCLIDE PRODUCTION METHOD, TARGET HOLDING DEVICE FOR QUANTUM BEAM IRRADIATION, SYSTEM, AND TARGET DAVIS, SHARON M 3646 §102§112 Non-Final OA — Pending May 23, 2024
18279282 POLYNUCLEOTIDE FOR TREATMENT OF NEURODEGENERATIVE DISEASE, VECTOR, CELL, PHARMACEUTICAL COMPOSITION, AND SCREENING METHOD GROOMS, TIFFANY NICOLE 1637 §103§112 Non-Final OA — Pending Mar 12, 2024
18591144 RECORDING MEDIUM, INFORMATION PROCESSING SYSTEM, AND DATA PROCESSING SYSTEM WONG, ERIC TAK WAI 3693 §101 Final Rejection 14d Pending Feb 29, 2024
18415906 COMPUTER-READABLE RECORDING MEDIUM, PATH SELECTING METHOD, AND PATH SELECTING APPARATUS KARTHOLY, REJI P 2143 §101§103 Non-Final OA — Pending Jan 18, 2024
18566868 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM LI, SUN M 3685 §101§112 Non-Final OA — Pending Dec 04, 2023
18565293 QUANTUM CASCADE LASER ELEMENT GOLUB-MILLER, MARCIA A — §102§112 Non-Final OA — Pending Nov 29, 2023
18553441 METHOD AND DEVICE FOR INDUCING HYPOMETABOLIC STATE IN SUBJECT WITH DISEASE ANTHONY, MARIA CATHERINE 3796 §102 Final Rejection 47d Pending Sep 29, 2023
18282174 COMPOUND, PRODUCTION METHOD THEREFOR, COMPLEX, AND SHORT WAVELENGTH INFRARED FLUORESCENT AGENT BAEK, JONGHWAN NMN 1618 §103 Final Rejection — Pending Sep 14, 2023
18549792 METHOD FOR PRODUCING HYPOIMMUNOGENIC RETINAL PIGMENT EPITHELIAL CELLS UNDERDAHL, THANE E 1699 §102 Final Rejection 41d Pending Sep 08, 2023
18034621 CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL EXPRESSING CXCL12 RECEPTOR DUNN, LINDSAY MICHELLE 1644 §101§102§103§112 Final Rejection 13d Pending Sep 07, 2023
18279628 METHODS FOR PRODUCING CAS3 PROTEINS MOAZZAMI, NAGHMEH NINA 1652 §103 Non-Final OA — Pending Sep 01, 2023
18447671 QUANTUM LOGIC GATE OPERATION DEVICE, QUANTUM LOGIC GATE OPERATION METHOD AND A NON-TRANSITORY COMPUTER-READABLE MEDIUM LUDWIG, PETER L 3627 §103 Non-Final OA — Pending Aug 10, 2023
18262792 PREVENTIVE OR THERAPEUTIC AGENT FOR BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY SU-TOBON, QIWEN NMN 1636 §103 Final Rejection 20d Pending Jul 25, 2023
18269264 METHOD AND KIT FOR DETECTING TARGET NUCLEIC ACID FRAGMENT BELLAH, JEFFREY LAWRENCE 1683 §103Other Final Rejection 23d overdue Pending Jun 22, 2023
18265609 METHOD FOR PRODUCING PLURIPOTENT STEM CELL POPULATION MONTANARI, DAVID A 1632 §102§103 Final Rejection — Pending Jun 06, 2023
18030133 THREE-DIMENSIONAL SHAPED OBJECT, METHOD FOR MANUFACTURING SAME, AND CONTROL PROGRAM TROCHE, EDGAREDMANUE 1744 §103 Final Rejection — Pending Apr 04, 2023
18028372 HAIR GROWTH AGENT HA, JULIE 1654 §102§103§112 Non-Final OA — Pending Mar 24, 2023
17928184 METHOD FOR TREATING CELL POPULATION AND METHOD FOR ANALYZING GENES INCLUDED IN CELL POPULATION CHUNDURU, SURYAPRABHA 1681 §102§103§112 Final Rejection 20d Pending Nov 28, 2022
17633353 COMBINED USE OF ARTIFICIAL ADJUVANT VECTOR CELLS AND AN IMMUNOSTIMULANT BARRERA, IMMACULADA 1671 §103 Final Rejection 19d overdue Pending Feb 07, 2022
17615065 OPTICAL INTERFERENCE MEASURING APPARATUS AND OPTICAL INTERFERENCE MEASURING METHOD SUN, XIUQIN 2857 §101 Final Rejection — Pending Nov 29, 2021
17280392 IN VITRO GROWTH METHOD FOR HAIR FOLLICULAR EPITHELIAL STEM CELLS BATES, KEENAN ALEXANDER 1631 §103 Non-Final OA — Pending Apr 27, 2021
19141052 OIL CONTROL RING KONERU, LAKSHMI S 3675 §103 Non-Final OA 70d Pending Jun 19, 2025
18721195 PISTON RING AND PISTON RING SET PATEL, VISHAL A 3675 §103Other Non-Final OA 26d overdue Pending Jun 18, 2024

Managing Riken's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Riken have?

Riken has 33 pending office actions as of October 2026, spread across 27 art units and 32 examiners.

Which USPTO examiner handles the most Riken applications?

Mary Evangeline Barr has the most, with 2 of Riken's pending office actions.

What technology area are Riken's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month